Advertisement

Topics

Cambridge bluegnome Company Profile

12:42 EST 17th December 2018 | BioPortfolio

BlueGnome was founded in 2001 by engineers and mathematicians from the University of Cambridge who observed that the analysis of data generated by high throughput experimental platforms, such as microarrays and NMR, could be fundamentally improved by the application of more advanced statistical methods.In collaboration with research, clinical and commercial laboratories BlueGnome has developed a complementary suite of software solutions and data analysis services to enable higher quality information to be extracted from microarrays, NMR and mass spectrometry data, while dramatically improving process automation and reducing costs.More recently, BlueGnome has extended its product range to include microarrays for use in clinical arrayCGH experiments and other applications. By pairing microarrays with its leading software, BlueGnome is able to provide an integrated and automated solution for extracting the highest quality information from arrayCGH experiments.

Location

Breaks House Mill Court
Great Shelford
Cambridge
Cambridgeshire
CB2 5LD
United Kingdom

Contact

Phone: 44 (0)1223 844441
Fax: 44 (0)1223 844445
Email: info@cambridgebluegnome.com


News Articles [211 Associated News Articles listed on BioPortfolio]

Cambridge Bancorp Announces Record Quarterly Earnings and Declares Dividend

CAMBRIDGE, Mass., Oct. 15, 2018 /PRNewswire/ -- Cambridge Bancorp (NASDAQ: CATC) (the "Company"), the parent of Cambridge Trust Company, today announced unaudited net income of Read more...

Nvidia Team Up With Cambridge Spin-Out To Create 'Broadband' For The Body

Cambridge University spin-out Cambridge Bio-Augmentation Systems (CBAS), has partnered with Nvidia to bring AI-powered edge-computing to the most powerful communication network: the nervous system.

Ahren Fund to Invest $10 Million in Cambridge Epigenetix

Eight so-called “superstar scientists” based in Cambridge, UK, have co-founded an investment fund dubbed Ahren with 100 million pounds, so far. One of their first investments is in biotech company...

Register Now for UKSPA in Cambridge, October 11 and 12, 2018

Registration is now open for UKSPA’s next meeting in October hosted by Cambridge Science Park with conference partner Bidwells. The outline programme can now be downloaded. Although most se...

#jobs #lifescience Cambridge Biotech seeking Office Manager/Executive Assistant!

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Cambridge Biotech seeking Office Manager/Executive Assistant! .MA-Cambridge, ...

AZ and CRUK launch Cambridge genomics centre

New centre adds to Cambridge's biotech cluster

#jobs #lifescience Senior Product Manager – Biotech – Cambridge

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Senior Product Manager – Biotech – Cambridge .MA-Cambridge, We ar...

PlaqueTec sets up new science base at Babraham Research campus in Cambridge

The company has also expanded its headquarters and device development facilities, which are now located in Cambourne Business Park, also in Cambridge. PlaqueTec is leading biomarker-based cardiovascul...

Drugs and Medications [5 Associated Drugs and Medications listed on BioPortfolio]

Polocaine [Dentsply Pharmaceutical]

3% Polocaine DENTAL (Mepivacaine Hydrochloride Injection, USP) 2% Polocaine DENTAL with Levonordefrin 1:20,000 (Mepivacaine Hydrochloride and Levonordefrin Injection, USP)

Xylocaine [Dentsply Pharmaceutical]

2% Xylocaine DENTAL with epinephrine 1:50,000 (Lidocaine HCl 2% and Epinephrine 1:50,000 Injection) 2% Xylocaine DENTAL with epinephrine 1:100,000 (Lidocaine HCl 2% and Epinephrine 1:100,000 Injection...

Articadent [Dentsply Pharmaceutical]

4% Articadent™ DENTAL with epinephrine 1:100,000 (Articaine hydrochloride 4% (40mg/mL) with epinephrine 1:100,000 injection) 4% Articadent™ DENTAL with epinephrine 1:200,000 (Articaine hydrochlori...

Gastromark [Mallinckrodt Inc.]

February 2010 300 mL 175 μg Fe/mL Gastromark™ [ferumoxsil, oral suspension] Mallinckrodt Inc. Rx only

Vivacaine [Septodont, Inc.]

Vivacaine™ Bupivacaine HCl 0.5% and Epinephrine 1:200,000 Injection (as bitartrate) (Bupivacaine Hydrochloride and Epinephrine Injection, USP)

Clinical Trials [32 Associated Clinical Trials listed on BioPortfolio]

Weight Loss for Obese Individuals With Gout

This study evaluates effect of weight loss in a group of obese patients with gouty arthritis. The study is a randomised group trial where half the patients receive intensive weight loss in...

PAN-study: Pan-Cancer Early Detection Study (PAN)

The PAN Cancer Early Detection study is a prospective cross-sectional observational case-control study evaluating whether Breath Biopsy (developed by Owlstone Medical Ltd.; the Sponsor of...

Color Vision as a Measure for Inherited Retinal Diseases

Background: - The purpose of this study is to find out whether color vision measured with the Cambridge Color Test is a good way to examine the severity of inherited retinal diseases (IRD...

Mayo AVC Registry and BioBank

Arrhythmogenic ventricular cardiomyopathy (AVC) is a genetic condition which affects the heart and can lead to heart failure and rhythm problems, of which, sudden cardiac arrest or death i...

Cambridge Anti-Myopia Trial: Accommodation Training and Aberration Control in Myopia Development

We have identified focussing problems related to myopia getting worse. Our trial uses optical and orthoptic interventions that correct the focussing problems to see if this retards myopia ...

Companies [398 Associated Companies listed on BioPortfolio]

Cambridge bluegnome

BlueGnome was founded in 2001 by engineers and mathematicians from the University of Cambridge who observed that the analysis of data generated by high throughput experimental platforms, such as micro...

Cambridge Cognition Ltd

Cambridge Cognition Ltd specialises in computerised cognitive testing. Based in Cambridge, England, the company supplies products and services based on CANTAB®, the Cambridge Neuropsychological Test ...

Cambridge Epigenetix

Cambridge Epigenetix’s mission is to improve health through the routine measurement of the epigenome. Cambridge Epigenetix utilizes innovative technologies, often based on fu...

Cambridge Biomedical, Inc.

Cambridge Biomedical is a contract research organization (CRO) and diagnostic laboratory providing bioanalytical support to the pharmaceutical, biotechnology, and medical d...

Funxional Therapeutics Limited

Funxional Therapeutics is a privately held, clinical stage pharmaceutical company based in Cambridge (UK) which focuses on novel anti-inflammatory therapies. FXT is managed by a very experienced t...

More Information about "Cambridge bluegnome" on BioPortfolio

We have published hundreds of Cambridge bluegnome news stories on BioPortfolio along with dozens of Cambridge bluegnome Clinical Trials and PubMed Articles about Cambridge bluegnome for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Cambridge bluegnome Companies in our database. You can also find out about relevant Cambridge bluegnome Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...


Corporate Database Quicklinks



Searches Linking to this Company Record